AU4981397A - Triterpene derivatives with immunosupressant activity - Google Patents

Triterpene derivatives with immunosupressant activity

Info

Publication number
AU4981397A
AU4981397A AU49813/97A AU4981397A AU4981397A AU 4981397 A AU4981397 A AU 4981397A AU 49813/97 A AU49813/97 A AU 49813/97A AU 4981397 A AU4981397 A AU 4981397A AU 4981397 A AU4981397 A AU 4981397A
Authority
AU
Australia
Prior art keywords
triterpene derivatives
immunosupressant
activity
immunosupressant activity
triterpene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49813/97A
Inventor
Robert K Baker
Jianming Bao
Frank Kayser
Andrew Kotliar
William H Parsons
Kathleen M. Rupprecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625887.6A external-priority patent/GB9625887D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4981397A publication Critical patent/AU4981397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49813/97A 1996-10-16 1997-10-10 Triterpene derivatives with immunosupressant activity Abandoned AU4981397A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2896396P 1996-10-16 1996-10-16
US60028963 1996-10-16
GB9625887 1996-12-12
GBGB9625887.6A GB9625887D0 (en) 1996-12-12 1996-12-12 Triterpene derivatives with immunosuppressant activity
PCT/US1997/018334 WO1998016531A1 (en) 1996-10-16 1997-10-10 Triterpene derivatives with immunosupressant activity

Publications (1)

Publication Number Publication Date
AU4981397A true AU4981397A (en) 1998-05-11

Family

ID=26310618

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49813/97A Abandoned AU4981397A (en) 1996-10-16 1997-10-10 Triterpene derivatives with immunosupressant activity

Country Status (2)

Country Link
AU (1) AU4981397A (en)
WO (1) WO1998016531A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408044D0 (en) * 1994-04-22 1994-06-15 Sod Conseils Rech Applic Conversion of ginkgolide c to ginkgolide b

Also Published As

Publication number Publication date
WO1998016531A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU1735497A (en) Sulfonylureidopyrazole derivatives
AUPM767694A0 (en) Support assembly
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU3131895A (en) Back support
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU3685097A (en) N-benzylazolium derivatives
AU3784695A (en) Immunosuppressive cyclolignan derivatives
AU4822597A (en) Triterpene derivatives with immunosuppressant activity
AU4981397A (en) Triterpene derivatives with immunosupressant activity
AU7873198A (en) Polysaccharide-peptide derivatives
AU1558497A (en) Micacocidin derivatives
AU2123797A (en) 2-thioxotetrahydropyrimidin-4-one derivatives
AU4813297A (en) Triterpene derivatives with immunosuppressant activity
AU3578595A (en) Quinazoline derivative
AU4134597A (en) Dc-89 derivatives
AUPO168996A0 (en) Structure
AU1903895A (en) Attachment
AU4850597A (en) Fabricated structural members
GB9603842D0 (en) Triterpene derivatives with immunosuppresent activity
GB9603833D0 (en) Triterpene derivatives with immunosuppressive activity
AU2977697A (en) 4-nitro-2-phenoxysulfonanilide derivatives
AU4536497A (en) N-benzylazolium derivatives
AU3463197A (en) Dc-89 derivatives